Role of factor VIII-binding capacity of endogenous von Willebrand factor in the development of factor VIII inhibitors in patients with severe hemophilia A

被引：3
|
作者：
Repesse, Yohann [1 ,2 ,3 ]
Costa, Catherine [4 ]
Palla, Roberta [5 ]
Moshai, Elika Farrokhi [6 ]
Borel-Derlon, Annie [1 ,2 ,3 ]
D'Oiron, Roseline [7 ]
Rothschild, Chantal [8 ]
El-Beshlawy, Amal [9 ]
Elalfy, Mohsen [10 ]
Ramanan, Vijay [11 ]
Eshghi, Peyman [12 ]
Oldenburg, Johannes [13 ]
Pavlova, Anna [13 ]
Rosendaal, Frits R. [14 ]
Peyvandi, Flora [5 ]
Kaveri, Srinivas V. [6 ]
Lacroix-Desmazes, Sebastien [6 ]
机构：
[1] CHU Caen, Hematol Lab, Caen, France
[2] INSERM, U1237, GIP Cyceron, Caen, France
[3] Normandie Univ, UNI CAEN, UFR Sante, Caen, France
[4] Grp Hosp Cochin Broca, AP HP, Hotel Dieu, Serv Genet & Biol Mol, Site Cochin, Paris, France
[5] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy
[6] Univ Paris Diderot, Sorbonne Univ, USPC, Ctr Rech Cordeliers,INSERM, Paris, France
[7] AP HP, Ctr Traitement Hemophilie, Le Kremlin Bicetre, France
[8] Hop Necker Enfants Malad, AP HP, Ctr Traitement Hemophilie, Paris, France
[9] Cairo Univ, Pediat Hosp, Pediat Hematol Dept, Cairo, Egypt
[10] Cairo Univ, Ain Shams Ctr, Dept Pediat, Fac Med, Cairo, Egypt
[11] Jehangir Hosp Premises, Jehangir Clin Dev Ctr, Dept Hematol, Pune, Maharashtra, India
[12] Shahid Beheshti Univ Med Sci, Pediat Congenital Hematol Disorders Res Ctr, Tehran, Iran
[13] Univ Clin Bonn, Inst Expt Hematol & Transfus Med, Bonn, Germany
[14] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands
来源：
HAEMATOLOGICA | 2019年 / 104卷 / 08期
关键词：
COAGULATION FACTOR-VIII; VONWILLEBRAND-FACTOR; FACTOR GENE; POLYMORPHISMS; MUTATIONS; IMMUNOGENICITY; ANTIBODIES; FVIII;
D O I：
10.3324/haematol.2018.212001
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E369 / E372
页数：4
相关论文
共 50 条
  • [31] Factor VIII Products and Inhibitor Development in Severe Hemophilia A
    Gouw, Samantha C.
    van der Bom, Johanna G.
    Ljung, Rolf
    Escuriola, Carmen
    Cid, Ana R.
    Claeyssens-Donadel, Segolene
    van Geet, Christel
    Kenet, Gili
    Makipernaa, Anne
    Molinari, Angelo Claudio
    Muntean, Wolfgang
    Kobelt, Rainer
    Rivard, George
    Santagostino, Elena
    Thomas, Angela
    van den Berg, H. Marijke
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (03) : 231 - 239
  • [32] Increasing levels of von Willebrand factor and factor VIII with age in patients affected by von Willebrand disease
    Biguzzi, Eugenia
    Siboni, Simona Maria
    le Cessie, Saskia
    Baronciani, Luciano
    Rosendaal, Frits R.
    van Hylckama Vlieg, Astrid
    Peyvandi, Flora
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2021, 19 (01) : 96 - 106
  • [33] Optimizing therapy with factor VIII von Willebrand factor concentrates in von Willebrand disease
    Federici, AB
    Mannucci, PM
    HAEMOPHILIA, 1998, 4 : 7 - 10
  • [34] The influence of von Willebrand factor on factor VIII activity measurements
    Butenas, S.
    Parhami-Seren, B.
    Mann, K. G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (01) : 132 - 137
  • [35] Changes in the levels of factor VIII and von Willebrand factor in the puerperium
    Huq, F. Y.
    Kulkarni, A.
    Agbim, E. C.
    Riddell, A.
    Tuddenham, E.
    Kadir, R. A.
    HAEMOPHILIA, 2012, 18 (02) : 241 - 245
  • [36] Immunoprotective effect of von Willebrand factor towards therapeutic factor VIII in experimental haemophilia A
    Delignat, S.
    Repesse, Y.
    Navarrete, A. -M.
    Meslier, Y.
    Gupta, N.
    Christophe, O. D.
    Kaveri, S. V.
    Lacroix-Desmazes, S.
    HAEMOPHILIA, 2012, 18 (02) : 248 - 254
  • [37] Molecular coevolution of coagulation factor VIII and von Willebrand factor
    Zakas, Philip M.
    Coyle, Christopher W.
    Brehm, Anja
    Bayer, Marion
    Solecka-Witulska, Barbara
    Radford, Caelan E.
    Brown, Christine
    Nesbitt, Kate
    Dwyer, Courtney
    Kannicht, Christoph
    Spencer, H. Trent
    Gaucher, Eric A.
    Doering, Christopher B.
    Lillicrap, David
    BLOOD ADVANCES, 2021, 5 (03) : 812 - 822
  • [38] Kinetics of factor VIII: C inhibitors and treatment response in severe hemophilia A patients
    Luna-Zaizar, H.
    Esparza-Flores, M. A.
    Lopez-Guido, B.
    Aguilar-Lopez, L. B.
    Cortes Alvarez, C. R.
    Jaloma-Cruz, A. R.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2009, 31 (06) : 673 - 682
  • [39] Von Willebrand factor modulates factor VIII immunogenicity: Comparative study of different factor VIII concentrates in a haemophilia A mouse model
    Behrmann, M
    Pasi, J
    Saint-Remy, JMR
    Kotitschke, R
    Kloff, M
    THROMBOSIS AND HAEMOSTASIS, 2002, 88 (02) : 221 - 229
  • [40] Evaluation of von Willebrand factor activity in factor VIII/von Willebrand factor concentrates with the automated von Willebrand factor: activity IL test
    Mori, Filippo
    Rossi, Paola
    Nardini, Ilaria
    Gambelli, Davide
    Farina, Claudio
    BLOOD COAGULATION & FIBRINOLYSIS, 2010, 21 (03) : 221 - 228
12345